Myriad Genetics
MYGN
#6699
Rank
C$0.91 B
Marketcap
C$9.79
Share price
-3.27%
Change (1 day)
-57.30%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.51 Billion

According to Myriad Genetics's latest financial reports the company has C$0.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$1.00 B-3.15%
2023-12-31$C$1.03 B-13.58%
2022-12-31$C$1.20 B-2.55%
2021-12-31$C$1.23 B
2020-06-30$C$1.24 B-12.56%
2019-06-30$C$1.42 B12.2%
2018-06-30$C$1.27 B27.33%
2017-06-30$C$0.99 B2.92%
2016-06-30$C$0.96 B17.34%
2015-06-30$C$0.82 B7.67%
2014-06-30$C$0.76 B0.16%
2013-06-30$C$0.76 B18.35%
2012-06-30$C$0.64 B18.48%
2011-06-30$C$0.54 B-7.46%
2010-06-30$C$0.59 B18.32%
2009-06-30$C$0.49 B15.07%
2008-06-30$C$0.43 B20.18%
2007-06-30$C$0.36 B30.09%
2006-06-30$C$0.27 B64.66%
2005-06-30$C$0.16 B-27.01%
2004-06-30$C$0.23 B4.78%
2003-06-30$C$0.22 B12.73%
2002-06-30$C$0.19 B-7.6%
2001-06-30$C$0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Bio-Rad Laboratories
BIO
C$9.30 B 1,707.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C$3.45 B 570.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C$0.4 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.36 B 1,524.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$70.82 B 13,651.07%๐Ÿ‡บ๐Ÿ‡ธ USA